Recordati Rare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RECORDATI RARE, and what generic alternatives to RECORDATI RARE drugs are available?
RECORDATI RARE has twelve approved drugs.
There are eleven US patents protecting RECORDATI RARE drugs.
There are two hundred and eighty-three patent family members on RECORDATI RARE drugs in sixty countries and fifty-one supplementary protection certificates in nineteen countries.
Summary for Recordati Rare
International Patents: | 283 |
US Patents: | 11 |
Tradenames: | 12 |
Ingredients: | 12 |
NDAs: | 12 |
Drugs and US Patents for Recordati Rare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recordati Rare | ISTURISA | osilodrostat phosphate | TABLET;ORAL | 212801-003 | Mar 6, 2020 | DISCN | Yes | No | 9,434,754 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-004 | Jun 29, 2018 | RX | Yes | No | 7,473,761 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Recordati Rare | ISTURISA | osilodrostat phosphate | TABLET;ORAL | 212801-002 | Mar 6, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-004 | Jun 29, 2018 | RX | Yes | No | 7,759,308 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-002 | Dec 15, 2014 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Recordati Rare | PEGANONE | ethotoin | TABLET;ORAL | 010841-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Recordati Rare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Recordati Rare | NEOPROFEN | ibuprofen lysine | INJECTABLE;INTRAVENOUS | 021903-001 | Apr 13, 2006 | 6,342,530 | ⤷ Try a Trial |
Recordati Rare | NEOPROFEN | ibuprofen lysine | INJECTABLE;INTRAVENOUS | 021903-001 | Apr 13, 2006 | 6,344,479 | ⤷ Try a Trial |
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-001 | Dec 15, 2014 | 6,225,284 | ⤷ Try a Trial |
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-002 | Dec 15, 2014 | 8,822,637 | ⤷ Try a Trial |
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-002 | Dec 15, 2014 | 6,225,284 | ⤷ Try a Trial |
Recordati Rare | SIGNIFOR LAR KIT | pasireotide pamoate | FOR SUSPENSION;INTRAMUSCULAR | 203255-003 | Dec 15, 2014 | 6,225,284 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RECORDATI RARE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 10 mg/mL, 2 mL vial | ➤ Subscribe | 2010-10-01 |
International Patents for Recordati Rare Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2006120484 | ⤷ Try a Trial |
Japan | 2013006852 | ⤷ Try a Trial |
Russian Federation | 2006101720 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2011088188 | ⤷ Try a Trial |
Guatemala | 200900302 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2008142153 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Recordati Rare Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1648934 | C20120019 00062 | Estonia | ⤷ Try a Trial | PRODUCT NAME: SIGNIFOR-PASIREOTIID;REG NO/DATE: C(2012) 2910 FINAL 24.04.2012 |
2523731 | CR 2020 00025 | Denmark | ⤷ Try a Trial | PRODUCT NAME: OSILODROSTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER OSILODROSTATDIHYDROGENFOSFAT; REG. NO/DATE: EU/1/19/1407 20200113 |
1648934 | PA2012016,C1648934 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PASIREOTIDUM; REGISTRATION NO/DATE: EU/1/12/753/001 - EU/1/12/753/012, 0120424 |
1686964 | 197 5005-2015 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: PASIREOTID ALEBO JEHO FARMACEUTICKY PRIJATEL- NA SOL ALEBO AKYKOLVEK JEHO HYDRAT; REGISTRATION NO/DATE: EU/1/12/753/001 - EU/1/12/753/017 20141119 |
1307486 | C300536 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PASIREOTIDE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN HET BIJZONDER PASIREOTIDEDI-ASPARTAAT; REGISTRATION NO/DATE: EU/1/12/753/001-012 20120424 |
1307486 | SPC/GB12/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CYCLO((4R)-4-(2-AMINOETHYLCARBAMOYLOXY)-L-PROLYL-L-PHENYLGLYCYL-D-TRYPTOPHYL-L-LYSYL-4-O-BENZYL-L-TYROSYL-L-PHENYLALANYL-)), PASIREOTIDE, OR SALTS THEREOF; REGISTERED: UK EU/1/12/753/001-012 20120424 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.